Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 21(22)2020 Nov 19.
Article in English | MEDLINE | ID: mdl-33228092

ABSTRACT

The enteric nervous system (ENS), located in the wall of the gastrointestinal (GI) tract, is characterized by complex organization and a high degree of neurochemical diversity of neurons. One of the less known active neuronal substances found in the enteric neurons is neuregulin 1 (NRG1), a factor known to be involved in the assurance of normal development of the nervous system. During the study, made up using the double immunofluorescence technique, the presence of NRG1 in the ENS of the selected segment of porcine large intestine (caecum, ascending and descending colon) was observed in physiological conditions, as well as under the impact of low and high doses of bisphenol A (BPA) which is commonly used in the production of plastics. In control animals in all types of the enteric plexuses, the percentage of NRG1-positive neurons oscillated around 20% of all neurons. The administration of BPA caused an increase in the number of NRG1-positive neurons in all types of the enteric plexuses and in all segments of the large intestine studied. The most visible changes were noted in the inner submucous plexus of the ascending colon, where in animals treated with high doses of BPA, the percentage of NRG1-positive neurons amounted to above 45% of all neuronal cells. The mechanisms of observed changes are not entirely clear, but probably result from neurotoxic, neurodegenerative and/or proinflammatory activity of BPA and are protective and adaptive in nature.


Subject(s)
Benzhydryl Compounds/toxicity , Endocrine Disruptors/toxicity , Enteric Nervous System/drug effects , Intestine, Large/drug effects , Neuregulin-1/genetics , Phenols/toxicity , Administration, Oral , Animals , Drug Administration Schedule , Enteric Nervous System/metabolism , Enteric Nervous System/pathology , Female , Gene Expression/drug effects , Intestine, Large/innervation , Intestine, Large/metabolism , Intestine, Large/pathology , Neuregulin-1/agonists , Neuregulin-1/metabolism , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Submucous Plexus/drug effects , Submucous Plexus/metabolism , Submucous Plexus/pathology , Swine
2.
J Biol Chem ; 286(22): 20087-99, 2011 Jun 03.
Article in English | MEDLINE | ID: mdl-21467033

ABSTRACT

Here, we demonstrate that troglitazone (Rezulin), a peroxisome proliferator-activated receptor agonist, acted in synergy with heregulin to induce massive cell death in breast cancer cells. Although the combination of heregulin and troglitazone (HRG/TGZ) induced both apoptosis and necrosis, the main mode of cell death was caspase-independent and occurred via necrosis. This combination increased generation of superoxide in mitochondria, which in turn destabilized mitochondria potential. Pretreatment with N-acetyl-l-cysteine and catalase expression ameliorated cell death induced by the combination treatment, indicating a role of oxidative stress in mediating HRG/TGZ-induced cell death. Notably, pretreatment with pyruvate significantly prevented the cell death, suggesting a potential mechanistic link between metabolic stress and HRG/TGZ-induced cell death. The activation of the HRG signaling axis has been considered as a poor prognostic factor in breast cancer and confers resistance to gefitinib (Iressa) and tamoxifen. However, our data presented here paradoxically suggest that HRG expression can actually be beneficial when it comes to treating breast cancer with peroxisome proliferator-activated receptor-γ ligands. Taken together, the combination of HRG and TGZ may provide a basis for the development of a novel strategy in the treatment of apoptosis-resistant and/or hormone-refractory breast cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Breast Neoplasms/drug therapy , Chromans/pharmacology , Membrane Potential, Mitochondrial/drug effects , Neuregulin-1/pharmacology , PPAR gamma/agonists , Thiazolidinediones/pharmacology , Antineoplastic Agents/agonists , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cell Line, Tumor , Chromans/agonists , Drug Synergism , Female , Humans , Necrosis , Neuregulin-1/agonists , Oxidative Stress/drug effects , PPAR gamma/genetics , PPAR gamma/metabolism , Signal Transduction/drug effects , Thiazolidinediones/agonists , Troglitazone
3.
Neurosci Res ; 70(2): 155-63, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21352860

ABSTRACT

The NRG1 growth factor and ERBB4 receptor have been identified as leading schizophrenia risk genes. Although NRG1 and ERBB4 have been shown to modulate neuronal functions involved in schizophrenia, including both GABAergic and glutamatergic synapses, the exact molecular mechanisms remain poorly understood. Here we investigated ERBB4 intracellular domain, 4ICD, transactivator function in rat hippocampal cultures by inhibiting γ-secretase mediated ERBB4 regulated intramembrane proteolysis (RIP). NRG1 stimulation resulted in a dramatic increase in the number of hippocampal cells displaying nuclear 4ICD which was abolished in cultures pretreated with the γ-secretase inhibitor compound E (CE). To identify NRG1-4ICD transactivated genes we compared global gene expression profiles of hippocampal cultures stimulated with NRG1 in the absence or presence of CE. In concordance with the contribution of NRG1-ERBB4 signaling to dendritic spine maturation and schizophrenia, global gene expression analysis followed by Ingenuity Pathway Analysis of the dataset identified NRG1-4ICD regulated genes significantly represented in semaphorin signaling and actin cytoskeletal plasticity and multiple genes with confirmed roles in dendritic spine morphogenesis. Using the power of global gene expression analysis our data provides a proof-of-concept supporting a role for non-canonical NRG1-4ICD signaling in the regulation of gene expression contributing to normal and schizophrenic neuronal function.


Subject(s)
ErbB Receptors/physiology , Gene Expression Regulation/physiology , Hippocampus/physiology , Intracellular Fluid/physiology , Neuregulin-1/physiology , Neurons/physiology , Animals , Cell Differentiation/genetics , Cells, Cultured , ErbB Receptors/chemistry , ErbB Receptors/genetics , Female , Gene Expression Profiling/methods , Hippocampus/pathology , Neuregulin-1/agonists , Neuregulin-1/genetics , Neuronal Plasticity/genetics , Neurons/cytology , Neurons/pathology , Protein Structure, Tertiary/genetics , Rats , Rats, Sprague-Dawley , Receptor, ErbB-4 , Schizophrenia/genetics , Schizophrenia/metabolism , Schizophrenia/pathology , Signal Transduction/genetics
4.
Mol Cell Biol ; 14(3): 1909-19, 1994 Mar.
Article in English | MEDLINE | ID: mdl-7509448

ABSTRACT

We used molecular cloning and functional analyses to extend the family of Neu differentiation factors (NDFs) and to explore the biochemical activity of different NDF isoforms. Exhaustive cloning revealed the existence of six distinct fibroblastic pro-NDFs, whose basic transmembrane structure includes an immunoglobulin-like motif and an epidermal growth factor (EGF)-like domain. Structural variation is confined to three domains: the C-terminal portion of the EGF-like domain (isoforms alpha and beta), the adjacent juxtamembrane stretch (isoforms 1 to 4), and the variable-length cytoplasmic domain (isoforms a, b, and c). Only certain combinations of the variable domains exist, and they display partial tissue specificity in their expression: pro-NDF-alpha 2 is the predominant form in mesenchymal cells, whereas pro-NDF-beta 1 is the major neuronal isoform. Only the transmembrane isoforms were glycosylated and secreted as biologically active 44-kDa glycoproteins, implying that the transmembrane domain functions as an internal signal peptide. Extensive glycosylation precedes proteolytic cleavage of pro-NDF but has no effect on receptor binding. By contrast, the EGF-like domain fully retains receptor binding activity when expressed separately, but its beta-type C terminus displays higher affinity than alpha-type NDFs. Likewise, structural heterogeneity of the cytoplasmic tails may determine isoform-specific rate of pro-NDF processing. Taken together, these results suggest that different NDF isoforms are generated by alternative splicing and perform distinct tissue-specific functions.


Subject(s)
Glycoproteins/chemistry , Neuregulin-1/agonists , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , DNA Primers/chemistry , DNA, Complementary/genetics , ErbB Receptors/metabolism , Gene Expression , Genes , Glycoproteins/genetics , Glycoproteins/physiology , Humans , Molecular Sequence Data , Molecular Weight , Neuregulins , Phosphotyrosine , Proto-Oncogene Proteins/metabolism , RNA, Messenger/genetics , Rats , Receptor, ErbB-2 , Recombinant Proteins , Sequence Alignment , Sequence Homology, Amino Acid , Transfection , Tyrosine/analogs & derivatives , Tyrosine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...